Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease

Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial

(2013) Robert J. Glynn   ANNALS OF INTERNAL MEDICINE

Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome

(2013) Lionel C Clement et al.   NATURE MEDICINE

Chapter 4: Pharmacological cholesterol-lowering treatment in children

(2013)   Kidney International Supplements

CKiD (CKD in Children) Prospective Cohort Study: A Review of Current Findings

(2012) Cynthia J. Wong et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline

(2012) Yelena Slinin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Cardiovascular risk assessment in children with chronic kidney disease

(2012) Rukshana Shroff et al.   PEDIATRIC NEPHROLOGY

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Dyslipidemia in children with CKD: should we treat with statins?

(2011) Kjell Tullus   PEDIATRIC NEPHROLOGY

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

(2008) Giovanni F M Strippoli et al.   BMJ-British Medical Journal

Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood

(2007) Costan G. Magnussen et al.   CIRCULATION